Your browser doesn't support javascript.
loading
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy.
Terashima, Yuto; Hakozaki, Taiki; Uehara, Yuji; Miyanaga, Akihiko; Kasahara, Kazuo; Seike, Masahiro; Hosomi, Yukio.
Affiliation
  • Terashima Y; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-0021, Japan.
  • Hakozaki T; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
  • Uehara Y; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-0021, Japan. t-hakozaki@akane.waseda.jp.
  • Miyanaga A; Graduate School of Advanced Science and Engineering, Faculty of Science and Engineering, Waseda University, Tokyo, Japan. t-hakozaki@akane.waseda.jp.
  • Kasahara K; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-Ku, Tokyo, 113-0021, Japan.
  • Seike M; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
  • Hosomi Y; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
Int J Clin Oncol ; 29(2): 115-123, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38032455

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antibodies, Monoclonal Limits: Humans Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Lung Neoplasms / Antibodies, Monoclonal Limits: Humans Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: Country of publication: